← All trials
NCT00672529
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2011
- Primary completion
- Mar 1, 2013
- Completion date
- Mar 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Canadian Institute of Natural and Integrative MedicineLead sponsor
- Canadian Institute of Natural and Integrative MedicineOverall official - principal investigator
- University of CalgaryOverall official - principal investigator
- University of AlbertaOverall official - principal investigator
- University of CalgaryCollaborator
- The Canadian College of Naturopathic MedicineOverall official - principal investigator
- Paradigm Health GroupOverall official - principal investigator
- Alberta Heritage Foundation for Medical ResearchCollaborator
- SickKids FoundationCollaborator
- Lotte & John Hecht Memorial FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.